Literature DB >> 6291451

Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.

M A Crosby, D W Gump.   

Abstract

A total of 102 isolates of Bacteroides spp. were studied for beta-lactamase production and susceptibility to cefoperazone alone or in combination with either of the beta-lactamase inhibitors sulbactam and clavulanic acid. The geometric mean minimal inhibitory concentration of cefoperazone alone was 31.5 micrograms/ml and when combined with 10 micrograms of sulbactam per ml or 2 micrograms of clavulanic acid per ml was reduced to 5.4 and 9.2 micrograms/ml, respectively. When bacterial suspensions were tested for beta-lactamase production with nitrocefin, 91 (89.2%) of these isolates produced the enzyme. The geometric mean minimal inhibitory concentrations of cefoperazone rose only slightly for isolates with low or intermediate enzyme activity but rose significantly for those with high activity. The addition of EDTA to cefoperazone significantly more frequently enhanced the activity of cefoperazone against beta-lactamase-negative as opposed to beta-lactamase-positive isolates. Furthermore, EDTA resulted in synergistic activity of the cefoperazone-sulbactam combination on beta-lactamase-positive isolates for which the combination had previously not shown a synergistic effect. This study demonstrates the relationship between beta-lactamase production and the resistance of Bacteroides spp. to cefoperazone and shows that inhibition of these enzymes can reverse this resistance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291451      PMCID: PMC183756          DOI: 10.1128/AAC.22.3.398

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.

Authors:  B Olsson; K Dornbusch; C E Nord
Journal:  Med Microbiol Immunol       Date:  1977-10-07       Impact factor: 3.402

2.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate.

Authors:  L Leive
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

4.  In vitro reversal of antibiotic resistance by ethylenediamine tetraacetic acid.

Authors:  R Weiser; A W Asscher; J Wimpenny
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

5.  Penicillin resistance in Staphylococcus aureus 893 not mediated by -lactamase.

Authors:  T J Bradley; J Wyatt
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

6.  Release of lipopolysaccharide by EDTA treatment of E. coli.

Authors:  L Leive
Journal:  Biochem Biophys Res Commun       Date:  1965-11-22       Impact factor: 3.575

7.  Release of lipopolysaccharide in Escherichia coli resistant to the permeability increase induced by ethylenediaminetetraacetate.

Authors:  M J Voll; L Leive
Journal:  J Biol Chem       Date:  1970-03-10       Impact factor: 5.157

8.  Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibiotics.

Authors:  R B Kammer; D A Preston; J R Turner; L C Hawley
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Cephalosporinase activity in Bacteroides fragilis.

Authors:  V E Del Bene; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

View more
  19 in total

1.  In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

Review 2.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.

Authors:  T Fekete; J McGowen; K R Cundy
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

4.  Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

5.  In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

Authors:  R N Jones; A L Barry; R R Packer; W W Gregory; C Thornsberry
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

Review 6.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

7.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

8.  Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.

Authors:  P C Appelbaum; M R Jacobs; S K Spangler; S Yamabe
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

9.  Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.

Authors:  T Kesado; K Watanabe; Y Asahi; M Isono; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

10.  Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.

Authors:  F Lamothe; F Auger; J M Lacroix
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.